Results 91 to 100 of about 20,079 (290)

Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

open access: yesBMC Medicine, 2020
Background Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited.
Duong Thuy Tran   +7 more
doaj   +1 more source

Varenicline as a Cause of Suicidal Outcomes [PDF]

open access: yesNicotine & Tobacco Research, 2015
Postmarketing analyses and case reports have associated varenicline use with suicidal behaviors. This article reviews postmarketing analyses, case reports, clinical trials, uncontrolled observational studies, controlled observational studies, and studies in smokers with psychiatric problems that have tested this association.The author searched the ...
openaire   +3 more sources

Nicotine pouches and clinical outcomes related to smoking cessation: A systematic review of randomized trials

open access: yesAddiction, EarlyView.
Abstract Background and aims Tobacco‐free nicotine pouches (NPs) are oral nicotine products promoted by manufacturers and some researchers as tools that may reduce nicotine cravings and support smoking reduction or cessation. However, evidence regarding their actual clinical impact remains limited.
Javad Heshmati   +6 more
wiley   +1 more source

Visual hallucinations associated with varenicline: a case report

open access: yesJournal of Medical Case Reports, 2009
Introduction Varenicline is widely used for smoking cessation. It has shown efficacy over placebo and bupropion in manufacturer-sponsored trials. Those with mental illness were excluded from these trials.
Raidoo B Mahendri, Kutscher Eric C
doaj   +1 more source

Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics. [PDF]

open access: yes, 2019
Mood disorders are highly prevalent and are the leading cause of disability worldwide. The neurobiological mechanisms underlying depression remain poorly understood, although theories regarding dysfunction within various neurotransmitter systems have ...
Dulawa, Stephanie C, Janowsky, David S
core  

Varenicline Induced Psychosis [PDF]

open access: yesKlinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012
(2012). Varenicline Induced Psychosis. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology: Vol. 22, No. 1, pp. 110-111.
Bilge Burçak Annagür   +2 more
openaire   +2 more sources

Perspectives on addiction‐related problems in Vietnam

open access: yesAddiction, EarlyView.
Abstract The article provides an overview of key substance use and addictive behaviors in Vietnam, alongside the development of addiction science, drawing from a synthesis of literature and the authors' perspectives. Over the last two decades, the primary illicit drug of concern has shifted from heroin to methamphetamine and other psychoactive ...
Nguyen Thu Trang   +4 more
wiley   +1 more source

Economic evaluation of smoking cessation in Ontario's regional cancer programs. [PDF]

open access: yes, 2018
Quitting smoking after a diagnosis of cancer results in greater response to treatment and decreased risk of disease recurrence and second primary cancers.
Cameron, Erin   +10 more
core   +1 more source

A genome-wide association study of nausea incidence in varenicline-treated cigarette smokers.

open access: yesNicotine & Tobacco Research, 2021
INTRODUCTION Varenicline is the most efficacious smoking cessation treatment, however long-term cessation rates tend to be
Meghan J. Chenoweth   +3 more
semanticscholar   +1 more source

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy